Cannabis and development of dual diagnoses: A literature review
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The use of cannabis has garnered more attention recently with ongoing efforts at marijuana legalization. The consequences of cannabis use are not clearly understood and remain a concern. OBJECTIVES: To review the acute and persistent effects of cannabis use and associations with psychiatric disorders. METHODS: Using Pubmed and PsychInfo, we conducted a narrative review of the literature on cannabis and psychiatric comorbidity using the keywords cannab*, marijuana, schizo*, psychosis, mood, depression, mania, bipolar, and anxiety. RESULTS: There is substantial evidence of cannabis use leading to other illicit drug use and of an association between cannabis use and psychosis. A few reports suggest an association with bipolar disorder while the association with depression and anxiety disorders is mixed. CONCLUSIONS: Whenever an association is observed between cannabis use and psychiatric disorders, the relationship is generally an adverse one. Age at the time of cannabis use appears to be an important factor with stronger associations observed between adolescent onset cannabis use and later onset of psychiatric disorders. Additional studies taking into account potential confounds (such as withdrawal symptoms, periods of abstinence, and other substance use) and moderators (such as age of initiation of cannabis use, the amount and frequency of drug use, prior history of childhood maltreatment, and gender) are needed to better understand the psychiatric consequences of cannabis use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Kandel, D. B., Yamaguchi, K., & Chen, K. (1992) · Journal of Studies on Alcohol · doi:10.15288/jsa.1992.53.447 · Cited by 1,039
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030 · cited 1×
“andglial differentiation (223,224) interacts with cannabis.”
Cannabis use and mental health in young people: cohort study.
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · cited 2×
“both anecdotal descriptions (34) and experimental studies (19,22,23,35) as well as greater cognitive impairment (23,29).”
BackgroundAction of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014) · Psychological Medicine · doi:10.1017/s0033291713001438 · Cited by 589
Exploring the association between cannabis use and depression.
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00437.x · Cited by 587
Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders.
Brook, D. W., Brook, J. S., Zhang, C., Cohen, P., & Whiteman, M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1039 · Cited by 527
Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt181 · Cited by 470
Young adult sequelae of adolescent cannabis use: an integrative analysis.
Silins, E., Horwood, L. J., Patton, G. C., Fergusson, D. M., Olsson, C. A., Hutchinson, D. M., Spry, E., Toumbourou, J. W., Degenhardt, L., Swift, W., et al. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70307-4 · Cited by 443 · cited 2×
“larly if cannabis use onset occurred during adolescence (65,149).”
BackgroundCannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420
Substance abuse in bipolar disorder
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.30403.x · Cited by 385
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Gage, S. H., Hickman, M., & Zammit, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.001 · Cited by 379
Wittchen, H.-U., Fröhlich, C., Behrendt, S., Günther, A., Rehm, J., Zimmermann, P., Lieb, R., & Perkonigg, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.12.013 · Cited by 311
Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077503 · Cited by 305
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300 · cited 1×
“Several studies report more severe positive psychotic symptoms when the THC/ CBD ratio is high (37,38), though this is not universal”
BackgroundKhan, S. S., Secades-Villa, R., Okuda, M., Wang, S., Pérez-Fuentes, G., Kerridge, B. T., & Blanco, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.015 · Cited by 293 · cited 1×
“female cannabis users (55,139,150) although the reverse has also been reported (151).”
BackgroundLisdahl, K. M., Gilbart, E. R., Wright, N. E., & Shollenbarger, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00053 · Cited by 284
Rubino, T., Realini, N., Braida, D., Guidi, S., Capurro, V., Viganò, D., Guidali, C., Pinter, M., Sala, M., Bartesaghi, R., et al. (2009) · Hippocampus · doi:10.1002/hipo.20554 · Cited by 282 · cited 1×
“neurotransmission (201,202) and leads to changes in neuronal morphology, with reduced spine density in the prefrontal cortex and hippocampus (192,193), reduced neurogenesis (203) and changes in white matter genes”
BackgroundSubstance use and withdrawal: neuropsychological functioning over 8 years in youth
TAPERT, S. F., GRANHOLM, E., LEEDY, N. G., & BROWN, S. A. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702870011 · Cited by 272
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.6.510 · Cited by 257
Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04015.x · Cited by 237 · cited 4×
“with a history of daily adolescent cannabis use (4).”
BackgroundInfluentialConfirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?
Van Laar, M., Van Dorsselaer, S., Monshouwer, K., & De Graaf, R. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01875.x · Cited by 224 · cited 1×
“associations between cannabis use and anxiety disorders (4,140) but others do not, particularly after controlling for potential confounds (142,179).”
BackgroundCannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212
Harley, M., Kelleher, I., Clarke, M., Lynch, F., Arseneault, L., Connor, D., Fitzpatrick, C., & Cannon, M. (2010) · Psychological Medicine · doi:10.1017/s0033291709991966 · Cited by 206 · cited 1×
“use and psychosis (99,100) with evidence of a dosedependent effect (101).”
BackgroundGenetic predisposition to schizophrenia associated with increased use of cannabis
Power, R. A., Verweij, K. J. H., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A. F., Medland, S. E., Wray, N. R., & Martin, N. G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.51 · Cited by 196
The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models
Rubino, T., & Parolaro, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.024 · Cited by 183 · cited 2×
“containing NMDA receptors to mainly GluN2Acontaining receptors in female rats (192), modulates GABA (γ-aminobutyric acid)-related gene expression and”
Backgroundvan Winkel, R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.152 · Cited by 183 · cited 1×
“oping psychosis (220) with heavier users showingmore risk”
BackgroundStrakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Arnold, L. M., & Amicone, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.57 · Cited by 165
Pacek, L. R., Martins, S. S., & Crum, R. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.059 · Cited by 164
Houston, J. E., Murphy, J., Adamson, G., Stringer, M., & Shevlin, M. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm127 · Cited by 162 · cited 1×
“use and psychosis (99,100) with evidence of a dosedependent effect (101).”
BackgroundZamberletti, E., Beggiato, S., Steardo, L., Prini, P., Antonelli, T., Ferraro, L., Rubino, T., & Parolaro, D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.028 · Cited by 147 · cited 1×
“neurotransmission (201,202) and leads to changes in neuronal morphology, with reduced spine density in the prefrontal cortex and hippocampus (192,193), reduced neurogenesis (203) and changes in white matter genes”
BackgroundMateos, B., Borcel, E., Loriga, R., Luesu, W., Bini, V, Llorente, R., Castelli, M., & Viveros, M.-P. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110370503 · Cited by 108
Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93 · cited 1×
“and schizophrenia comparison groups (30).”
Gleason, K. A., Birnbaum, S. G., Shukla, A., & Ghose, S. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.122 · Cited by 77
Self-citationHarder, V. S., Stuart, E. A., & Anthony, J. C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn184 · Cited by 76
Marmorstein, N. R., & Iacono, W. G. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.02.006 · Cited by 54
Cited by
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Hser, Y.-I., Mooney, L. J., Huang, D., Zhu, Y., Tomko, R. L., McClure, E., Chou, C.-P., & Gray, K. M. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.07.012 · Cited by 127
Marijuana and acute health care contacts in Colorado
Wang, G. S., Hall, K., Vigil, D., Banerji, S., Monte, A., & VanDyke, M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.03.022 · Cited by 77
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
MacCallum, C. A., Lo, L. A., & Boivin, M. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.05.002 · Cited by 71
Xue, S., Husain, M. I., Zhao, H., & Ravindran, A. V. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720952251 · Cited by 65
Metadata
- Authors
- Hanna, R. C., Perez, J. M., & Ghose, S.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2016-09-09
- Volume
- 43
- Issue
- 4
- Pages
- 442-455
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2507445866
- Cited by
- 85
- References
- 45
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.